Also trades as: CUV.AX (ASX) · $vol 1M · CLVLY (OTC) · $vol 0M

$5.68

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $286.3M mcap · 42M float · 0.0029% daily turnover · Short 69% of daily vol

Revenue

$94M -1.2% ▼

5Y CAGR: +14.2%

Gross Profit

$78M -1.2% ▼

5Y CAGR: +12.6%

Operating Income

$40M -11.5% ▼

5Y CAGR: +6.6%

Net Income

$34M -6.4% ▼

5Y CAGR: +6.5%

EPS (Diluted)

$0.68 -5.6% ▼

5Y CAGR: +7.2%

EBITDA

$41M -28.1% ▼

5Y CAGR: +7.8%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$66M	$78M	$88M	$95M	$94M
YoY Growth	+36.0%	+19.2%	+12.6%	+7.8%	-1.2%
Cost of Revenue	$10M	$9M	$8M	$16M	$16M
Gross Profit	$55M	$70M	$80M	$79M	$78M
Gross Margin	84.0%	88.8%	91.2%	83.3%	83.3%
R&D Expenses	$1M	$1M	$0	$0	$0
SG&A Expenses	$18M	$23M	$25M	$27M	$20M
Operating Expenses	$20M	$25M	$31M	$33M	$38M
Operating Income	$36M	$45M	$48M	$46M	$40M
Operating Margin	54.9%	57.3%	54.4%	48.1%	43.1%
Interest Expense	$2M	$3M	$4M	$4M	$81K
Income Before Tax	$34M	$46M	$51M	$52M	$48M
Tax Expense	$13M	$15M	$15M	$15M	$14M
Net Income	$21M	$31M	$36M	$36M	$34M
Net Margin	31.8%	39.1%	40.4%	38.1%	36.1%
EPS (Diluted)	$0.40	$0.59	$0.70	$0.72	$0.68
EBITDA	$37M	$50M	$56M	$57M	$41M
Shares Outstanding	52M	52M	51M	50M	50M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$29M	$49M	$33M	$56M	$36M	$59M	$37M	$57M
Cost of Revenue	$8M	$15M	$15M	$15M	$3M	$19M	$16M	$620K
Gross Profit	$21M	$33M	$17M	$41M	$33M	$41M	$21M	$56M
Gross Margin	71.3%	68.4%	51.6%	73.3%	91.4%	68.4%	56.2%	98.9%
R&D Expenses	$590K	$678K	$752K	$2M	$3M	$5M	$3M	$15M
SG&A Expenses	$7M	$5M	$5M	$14M	$13M	$9M	$6M	$12M
Operating Expenses	$8M	$6M	$6M	$9M	$16M	$14M	$10M	$27M
Operating Income	$13M	$28M	$14M	$32M	$17M	$27M	$11M	$30M
Operating Margin	44.2%	57.0%	44.1%	57.6%	47.4%	45.4%	29.7%	51.8%
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$15M	$31M	$15M	$36M	$22M	$30M	$15M	$33M
Tax Expense	$3M	$12M	$4M	$11M	$8M	$8M	$4M	$10M
Net Income	$11M	$19M	$11M	$25M	$14M	$22M	$10M	$23M
Net Margin	38.8%	39.2%	33.3%	44.2%	39.5%	37.2%	28.3%	41.1%
EPS (Diluted)	$0.22	$0.37	$0.21	$0.49	$0.28	$0.44	$0.21	$0.47
EBITDA	$7M	$15M	$21M	$35M	$17M	$30M	$11M	$30M
Shares Outstanding	52M	52M	52M	50M	50M	50M	51M	50M

CLVLF OTC